#Medifocus Granted New US Patent for Thermoactivated Release Method Medifocus Inc. TSXV: MFS, OTCQX: MDFZF) was issued a new patent by the United states Patent and Trademark Office: pparatus and Method for Preconditioning/Fixation and Treatment of Disease with Heat Activation/Release with Thermoactivated Drugs and Gene Productsauthored by John Mon, COO for Medifocus. As quoted in the press release: The Title of the patent is pparatus and Method for Preconditioning/Fixation and Treatment of Disease with Heat Activation/Release with Thermoactivated Drugs and Gene Products. The author of this patent is John Mon, COO for Medifocus. John Mon stated, his patent, along with the other recently issued patents, allows Medifocus to partner up with other biotech companies in helping to develop and commercialize targeted thermoactivated/released drugs and gene products which, in our opinion, is the future of medicine. f
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011